Literature DB >> 30578134

Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides.

Vanessa A Sanders1, David Iskhakov2, Dalya Abdel-Atti3, Matthew Devany2, Michelle C Neary2, Ken R Czerwinski4, Lynn C Francesconi5.   

Abstract

A pentapeptide macrocyclic ligand, KYCAR (lysyl-tyrosyl-cystyl-alanyl-arginine), has been designed as a potential chelating ligand for SPECT imaging and therapeutic in vivo agents. This study shows the synthesis and characterization of KYCAR complexes containing nonradioactive rhenium, 99mTc, or 188Re. The metal complexes were also biologically evaluated to determine in vivo distribution in healthy mice. The overall goals of this project were (1) to synthesize the Tc/Re pentapeptide complexes, (2) to identify spectroscopic methods for characterization of syn versus anti rhenium peptide complexes, (3) to analyze the ex vivo stability, and (4) to assess the biological properties of the [99mTc]TcO-KYCAR and [188Re]ReO-KYCAR complexes in vivo. Details on these efforts are provided below. <br> METHODS: NatRe/99mTc/188ReO-KYCAR complexes were synthesized, and macroscopic species were characterized via HPLC, IR, NMR, and CD. These characterization data were compared to the crystallographic data of ReO-KYC to assist in the assignment of diastereomers and to aid in the determination of the structure of the complex. <br> RESULTS: The radiometal complexes were synthesized with high purity (>95%). HPLC, IR, NMR and CD data on the macroscopic natReO-KYCAR complexes confirm the successful complexation as well as the presence of two diastereomers in syn and anticonformations. Tracer level complexes show favorable stabilities ex vivo for 2+ h. <br> CONCLUSION: Macroscopic metal complexes form diastereomers with the KYCAR ligand; however, this phenomenon is not readily observed on the tracer level due to the rapid interconversion. It was determined through pKa measurements that the macroscopic natReO-KYCAR complex is 0 at physiological pH. The [99mTc]TcO-KYCAR is stable in vitro while the [188Re]ReO-KYCAR shows 50% decomposition in PBS and serum. Biologically, the tracer level complexes clear through the hepatobiliary pathway. Some decomposition of both tracers is evident by uptake in the thyroid and stomach.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (188)Re; (99m)Tc; KYCAR; Metal peptide complex; Radiometals; SPECT

Mesh:

Substances:

Year:  2018        PMID: 30578134      PMCID: PMC6451878          DOI: 10.1016/j.nucmedbio.2018.11.001

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  32 in total

1.  Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study.

Authors:  E Wong; S Bennett; B Lawrence; T Fauconnier; L F Lu; R A Bell; J R Thornback; D Eshima
Journal:  Inorg Chem       Date:  2001-10-22       Impact factor: 5.165

Review 2.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Authors:  Tarik F Massoud; Sanjiv S Gambhir
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

Review 3.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Therapeutic radiopharmaceuticals.

Authors:  M T Ercan; M Caglar
Journal:  Curr Pharm Des       Date:  2000-07       Impact factor: 3.116

5.  New N(3)S donor ligand small peptide analogues of the N-mercaptoacetyl-glycylglycylglycine ligand in the clinically used Tc-99m renal imaging agent: evidence for unusual amide oxygen coordination by two new ligands.

Authors:  Malgorzata Lipowska; Lory Hansen; Xiaolong Xu; Patricia A Marzilli; Andrew Taylor; Luigi G Marzilli
Journal:  Inorg Chem       Date:  2002-06-03       Impact factor: 5.165

6.  Spectroscopic characterization of metal bound phytochelatin analogue (Glu-Cys)4-Gly.

Authors:  Yongsheng Cheng; Yong-Bin Yan; Jinyuan Liu
Journal:  J Inorg Biochem       Date:  2005-10       Impact factor: 4.155

7.  Rhenium(V) and Technetium(V) Oxo Complexes of an N(2)N'S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations.

Authors:  Ernest Wong; Theresa Fauconnier; Samantha Bennett; John Valliant; Tam Nguyen; Frank Lau; Linda F. L. Lu; Alfred Pollak; Russell A. Bell; John R. Thornback
Journal:  Inorg Chem       Date:  1997-12-03       Impact factor: 5.165

8.  Preparation and characterization of [99TcO] apcitide: a technetium labeled peptide.

Authors:  Lynn C Francesconi; Yongyong Zheng; Judit Bartis; Michael Blumenstein; Catherine Costello; Mark A De Rosch
Journal:  Inorg Chem       Date:  2004-05-03       Impact factor: 5.165

9.  Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.

Authors:  D J Canney; J Billings; L C Francesconi; Y Z Guo; B S Haggerty; A L Rheingold; H F Kung
Journal:  J Med Chem       Date:  1993-04-16       Impact factor: 7.446

Review 10.  Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials.

Authors:  Jae Min Jeong; June-Key Chung
Journal:  Cancer Biother Radiopharm       Date:  2003-10       Impact factor: 3.099

View more
  2 in total

Review 1.  Bifunctional chelators for radiorhenium: past, present and future outlook.

Authors:  Diana R Melis; Andrew R Burgoyne; Maarten Ooms; Gilles Gasser
Journal:  RSC Med Chem       Date:  2022-01-14

2.  [99mTc]Tc-DTPA-Bis(cholineethylamine) as an Oncologic Tracer for the Detection of Choline Transporter (ChT) and Choline Kinase (ChK) Expression in Cancer.

Authors:  Ambika Parmar Jaswal; Puja Panwar Hazari; Surbhi Prakash; Pallavi Sethi; Aruna Kaushik; Bal G Roy; Swati Kathait; Baljinder Singh; Anil Kumar Mishra
Journal:  ACS Omega       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.